Virbac Offers Exciting Complimentary Livestream Event For ‘Mast Cell Tumour (MCT) May’
2 years ago 
783 views
Following the launch of STELFONTA®, the breakthrough intratumoural solution to treat mast cell tumours in dogs, Virbac are delighted to offer a brand new interactive livestream event with guest speaker Dr Gerry Polton (RCVS & European Specialist in Veterinary Oncology).
MCTs are the most common form of skin cancer in dogs, accounting for up to 21% of skin cancer cases1. Therefore understanding the challenges surrounding mast cell tumour diagnosis, work up (including the various prognostic panels) and treatment selection for mast cell tumour cases is vital. The session will conclude with a review of Virbac’s game changing STELFONTA®, walking through cases and how to get the best results.
The session, entitled ‘Fundamentals of Mast Cell Tumour Management’, will be streamed on Tuesday 17th May at 8pm and registration is available here: https://tinyurl.com/mct-masterclass
‘We know that vets are facing webinar fatigue’ says Dr Neil Mottram MRCVS, Technical Product Manager at Virbac. ‘We therefore hope that this brand new style of online learning on one of the most common canine cancers will be more engaging, whilst still delivering high quality CPD’.
For more information on STELFONTA®, please speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Virbac is a unique, global and family run company dedicated exclusively to animal health for over 50 years. Virbac offers a wide portfolio of innovative and award-winning products that combine quality, effectiveness and convenience for veterinary surgeons, nurses and pet owners alike.
Virbac Limited, Woolpit Business Park, Windmill Avenue, Bury St Edmunds, Suffolk, IP30 9UP
Tel: 01359 243243 Email: [email protected] W: www.virbac.co.uk
Garrett, L.D. (2014) Canine mast cell tumors: diagnosis, treatment, and prognosis. Veterinary Medicine: Research and Reports, Vol 5. https://doi.org/10.2147/VMRR.S41005
More from Virbac Animal Health
2 days ago